MOONLAKE IMMUNOTHERAPEUTICS earnings per share and revenue

MLTX/N earnings per share for the last quarter are -15.01 MXN whereas the estimation was -12.93 MXN which accounts for -16.08% surprise. Company revenue for the same period amounts to 0.00 MXN despite the estimated figure of 0.00 MXN. Estimated earnings per share for the next quarter are -15.23 MXN, and revenue is expected to reach 0.00 MXN. Also watch annual changes over time to get a bigger picture of MLTX/N earnings per share and revenue dynamics.